---
title: "\"Profil World\" - The clinical diabetes research newsletter - February 2019 (Clone)"
description: "Latest \"Profil World\" edition about our free online seminar on glucose clamp studies, oral basal insulin in type 2 diabetes and glucose-responsive insulin."
image: https://blog.profil.com/hubfs/Glucose-clamp-studies_webinar_on-demand_linked-in_637x340.png
---

[![profil-logo-wortbild-with claim-4c-offset_1000px](https://blog.profil.com/hs-fs/hubfs/profil-logo-wortbild-with%20claim-4c-offset_1000px.png?width=250&name=profil-logo-wortbild-with%20claim-4c-offset_1000px.png "profil-logo-wortbild-with claim-4c-offset_1000px")](https://www.profil.com)

<https://www.profil.com/en/search>

[![Contact](https://no-cache.hubspot.com/cta/default/481167/1f89c7d1-107f-4c8d-aa7b-f85d0dce14da.png)](https://cta-redirect.hubspot.com/cta/redirect/481167/1f89c7d1-107f-4c8d-aa7b-f85d0dce14da)

[Patient information](https://www.profil.de)

![Header_1077x260px_About_Profil.jpg](https://blog.profil.com/hs-fs/hubfs/BLUE_MOON/Header/Header_1077x260px_About_Profil.jpg?width=1077&name=Header_1077x260px_About_Profil.jpg "Header_1077x260px_About_Profil.jpg")

# "Profil World" - The clinical diabetes research newsletter - February 2019 (Clone)

![Svenya](https://blog.profil.com/hubfs/Svenya_Meister_Hexagon.png)

Posted by [Svenya Meister](https://blog.profil.com/blog-test/author/svenya-meister)  on Oct 7, 2021 10:26:36 AM

![Two clicks for more privacy: The linkedin Share button will be enabled once you click here. Activating the button already sends data to linkedin.](https://cdn2.hubspot.net/hub/3825816/hubfs/BM/IN.png?width=20&name=IN.png "Two clicks for more privacy: The linkedin Share button will be enabled once you click here. Activating the button already sends data to linkedin.")

![Two clicks for more privacy: The Twitter Share button will be enabled once you click here.
                          Activating the button already sends data to Twitter.](https://blog.profil.com/hubfs/BLUE_MOON/twitter.png "Two clicks for more privacy: The Twitter Share button will be enabled once you click here.
                            Activating the button already sends data to Twitter.")

Dear all,

Greetings from Germany! I am happy to share with you the newest edition of "Profil World" - our newsletter filled with information about clinical research in diabetes and obesity.

### Free live Online Seminar: Understanding the results of glucose clamp studies

![Glucose-clamp-studies_webinar_on-demand_linked-in_637x340](https://blog.profil.com/hs-fs/hubfs/Glucose-clamp-studies_webinar_on-demand_linked-in_637x340.png?width=210&name=Glucose-clamp-studies_webinar_on-demand_linked-in_637x340.png)Join us for our next online seminar titled: "Understanding the results of glucose clamp studies". It will take place on March 5th at 4 PM CEST. Dr. Tim Heise, Lead Scientist and chairman of the board of directors at Profil, will be presenting the insights into this topic. Make sure not to miss this unique opportunity. [Register here](https://info.profil.com/webinar-understanding-the-results-of-glucose-clamp-studies).

 

### Glucose-responsive insulin

![medical-technolgoy-research_210x110](https://blog.profil.com/hs-fs/hubfs/medical-technolgoy-research_210x110.jpg?width=210&name=medical-technolgoy-research_210x110.jpg)The first idea for a glucose-responsive insulin (GRI, commonly referred to as smart insulin) was pitched almost 40 years ago, but to our knowledge only one compound has since undergone clinical evaluation. The concept may be simple, suggested solutions are complex and diverse. [Read our blog post](https://blog.profil.com/blog/glucose-responsive-insulin) on glucose-responsive insulin.

 

### Profil recently published a study on oral basal insulin in type 2 diabetes

![0090_RGB__](https://blog.profil.com/hs-fs/hubfs/0090_RGB__.jpg?width=210&name=0090_RGB__.jpg)[Read our publication](https://www.ncbi.nlm.nih.gov/pubmed/30679095) on the efficacy and safety of oral basal insulin versus subcutaneous insulin glargine in type 2 diabetes. The study was a randomised, double-blind, phase 2 trial. If you are interested in our other publications please [click here](https://www.profil.com/knowledge-center/publications).

 

 

Meet us at upcoming conferences 

![Fotolia_14.06.2013_23704610__](https://blog.profil.com/hs-fs/hubfs/Fotolia_14.06.2013_23704610__.jpg?width=210&name=Fotolia_14.06.2013_23704610__.jpg)

Are you interested in knowing more about Profil? We attend all major conferences focused on diabetes, so if you are planning to go to any upcoming conference, we would love to [schedule a meeting](https://info.profil.com/meet-profil-at-a-conference) and tell you more about our expertise!

Upcoming events: DGPharMed in Berlin (3/28-29/2019), DDG in Berlin (5/29-6/1/2019), ADA in San Francisco (6/7-11/2019)

 

We wish you a good week and look forward to the next "Profil World",

Svenya Meister - Online Marketing Manager

 

 Topics: [About Profil](https://blog.profil.com/blog-test/topic/about-profil)

### Subscribe to monthly E-Mail-Update

### Our most popular Posts

### Posts by Topic

- [About Profil (3)](https://blog.profil.com/blog-test/tag/about-profil)
- [Clinical Trials in Diabetes (2)](https://blog.profil.com/blog-test/tag/clinical-trials-in-diabetes)
- [Clinical Trial Methods (1)](https://blog.profil.com/blog-test/tag/clinical-trial-methods)
- [Treating Diabetes (1)](https://blog.profil.com/blog-test/tag/treating-diabetes)

## You might also like this post

### ["What are glucose clamps and why do we need them?"](https://blog.profil.com/blog/what-are-glucose-clamps-and-why-do-we-need-them)